Writing for Human and AI Reviewers: The New Way to File
The rise of automated FDA AI reviewers means mastering the balance between machine-readable data and clear medical storytelling. It is no longer optional—it is the key to avoiding costly filing delays.
How AI Is Reducing Drug Development Timelines From Years to Months
Today, artificial intelligence (AI) is changing this story. With the help of AI, scientists and companies are finding ways to shrink drug development timelines from years to months. Reshaping the pharmaceutical industry can accelerate drug development, improve efficiency, and potentially increase the success of projects.